view the price, resistance, support, chart of Aurobindo Pharma Limited and plot charts along with its volumes. Also see the 52-week high and low prices. Aurobindo Pharma Limited. Stock Code: NSE » AUROPHARMA AND BSE
Aurobindo Pharma Stock Trends in 2018. The share price of Aurobindo Pharma on January 1, 2018, was Rs.690 on NSE and BSE. The stock price over the course of the month declined, indicating the start of a bearish trend. The company also updated its investors presentation in the same period. Aurobindo Pharma Ltd Stock Price (526.90) - Check here Aurobindo Pharma Ltd share price today live, Aurobindo Pharma Ltd stock price, Aurobindo Pharma Ltd NSE/BSE share price live, financial Aurobindo Pharma Ltd. is in Pharmaceuticals & Drugs. It was incorporated in year 1986. The current market capitalisation stands Rs 36261 Cr. The company is listed on the Bombay Stock Exchange (BSE) with the BSE code as 524804. and also listed on National Stock Exchange (NSE) with NSE code as AUROPHARMA. Aurobindo Pharma Ltd NSE/BSE share price Live, News, stock performance, dividend, financials, share Holdings, balance sheet, charts and more at capital market Get Share Stock Price of AUROBINDO PHARMA LTD. on BSE. Get Live BSE quote for AUROBINDO PHARMA LTD.. Get AUROBINDO PHARMA LTD. stock price graph, announcements, corporate actions, financial reports, results, shareholding pattern, peer companies comparison and more. F&O Quote of Aurobindo Pharma Share Price, Future and Options Aurobindo Pharma Live BSE, NSE Charts, historical charts, F&O Quote, Stock quote of Aurobindo Pharma, Aurobindo Pharma News, Videos Aurobindo Pharma Ltd Stock/Share prices, Live BSE/NSE, F&O Quote of Aurobindo Pharma Ltd. with Historic price charts for NSE / BSE. detailed news, announcements, financial report, company information, annual report, balance sheet, profit & loss account, results and more.
AUROBINDO PHARMA : End-of-day quote, intraday chart, variations, volumes, technical indicators and last transactions, share AUROBINDO PHARMA | NSE India Stock Exchange: AUROPHARMA | NSE India Stock Exchange. AUROBINDO PHARMA : End-of-day quote, intraday chart, variations, volumes, technical indicators and last transactions, share AUROBINDO
Aurobindo Pharma Ltd ( AUROPHARMA ) - Get latest Aurobindo Pharma Ltd Share Price live, Historical Charts, Volume, Stock Performance, Quotes & company details. Stay updated with the Aurobindo Pharma Ltd Announcements, News & expert updates on shares. Aurobindo Pharma Limited was founded in 1986 and is based in Hyderabad, India. Aurobindo Pharma operates under Drug Manufacturers - Specialty Generic classification in India and is traded on Bombay Stock Exchange.. The public information regarding AUROBINDO PHARMA LTD's current market price is not available at this time. AUROBINDO PHARMA SHARE AURO PHARMA CHART ANALYSIS STOCK ABOVE 200 DMA LEVEL LEVELS AND TARGET Thanks for watching. Please like the video , share with friends and Subscribe the This video is unavailable. Watch Queue Queue. Watch Queue Queue Queue The stock, which had zoomed nearly 20% following the US FDA's voluntary-action-initiated status, tumbled about 15% on Monday. The BSE Healthcare Index was down 1.5%. Aurobindo Pharma Share Price Graph About the company - Incorporated by K.Nityananda Reddy and P.V. Ramaprasad Reddy in 1986 it started a business by manufacturing SSP (semi-synthetic penicillin) from a single manufacturing unit situated at Puducherry (then Pondicherry). Watch Aurobindo Pharma stock price move in real-time ahead here. Aurobindo Pharma will be releasing earnings for the most recent quarter on November 12.
Stock Tips - Free Intraday Stock Market Tips of Aurobindo Pharma Limited Current AUROPHARMA Stock Price & Stock Information ‣ Best time to take position: After 10.30 am morning. Updated on 17th Mar 2020 Evening after Share Market - only valid for Intraday Shares & Stocks Trading
Aurobindo Pharma Stock/Share prices,Aurobindo Pharma BSE/NSE. Get Aurobindo Pharma detailed intraday reports, stock/share price updates and market performance. This is the main Aurobindo Pharma Ltd. stock chart and current price. You can find more details by going to one of the sections under this page such as historical data, charts, technical analysis Aurobindo Pharma Ltd has added 17.1% over last one month compared to 3.08% gain in S&P BSE Healthcare index and 0.69% drop in the SENSEX. On the BSE, 1.21 lakh shares were traded in the counter so far compared with average daily volumes of 1.97 lakh shares in the past one month. Aurobindo Pharm Options Get stock options, options trading tips, call options, nifty options, Aurobindo Pharm options strategies, option chain details on Moneycontrol. Aurobindo Pharma. NSE BSE. 470.35-39.55 (-7.76 %) Volume: 511,328 Mar 09, 2020 4:00 PM * 5-minute snapshot prices. SECTIONS : [LIVE] Aurobindo Pharma share price details along with futures & options quotes. Get detailed report, 52 Week High / Low and company news on Nirmal Bang Disciplinary History: SEBI has not imposed any penalties against the company or its directors for any economic offence and / or for violation of any securities laws, either in respect to advisory services being offered by us, or any other matter related to capital market, as on date. Stock prices data is sourced from BSE and is 5 mins delayed data.
Stock analysis for Aurobindo Pharma Ltd (ARBP:Natl India) including stock price, stock chart, company news, key statistics, fundamentals and company profile.
Price: Rs. 816. About the Company. Aurobindo Pharma Limited is a leading global pharmaceutical company, producing generic formulations and Active Pharmaceutical Ingredients (APIs). Nearly 90% of the Company's revenue is driven by its international operations. Aurobindo Pharma Limited (Aurobindo) reported in-line results for Q2FY2020. Sales grew strongly by 18% to Rs. 5,600 crore because of sturdy growth in the U.S. and Europe formulations business. Operating profit grew by 14% y-o-y to Rs. 1,168 crore, while adjusted PAT was almost flat y-o-y to Rs. 679.5 crore, in line with our estimates. Shares of Aurobindo Pharma dropped over 4 per cent in early trade today following media reports that 20 US states have filed a lawsuit against the company alleging price manipulation of two drugs. On alleged fixing of drug prices. It is difficult to ascertain a definite timeline and just for investigation. The news could weigh heavily on the Aurobindo Pharma stock sentimentally, depending on the future news flow. The management has clarified that the drug being probed (Glyburide) contributed ~Rs7-8 crore to the company's sales in FY2016.
Aurobindo Pharma (Aurbindo) has a strong portfolio of 403 cumulative ANDA filings in the US stock with one-year target price of Rs998, based on 20x FY18E earnings. Financial Summary . INB231097537/ INF231097537/ INE231097537, Bombay Stock Exchange Ltd. SEBI Regn. No.:INB011097533/ INF011097533/ BSE-Currency, MCX Stock Exchange Ltd. SEBI